Sotera Health (NASDAQ:SHC) Given Average Recommendation of “Moderate Buy” by Analysts

Sotera Health (NASDAQ:SHC) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $16.08.

Several analysts recently commented on the company. Citigroup raised their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a research note on Thursday, November 21st.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $13.71 on Tuesday. The stock has a market cap of $3.88 billion, a PE ratio of 54.84 and a beta of 1.91. The firm has a fifty day moving average price of $13.31 and a 200 day moving average price of $14.56. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.18 earnings per share. Equities research analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in SHC. Darsana Capital Partners LP grew its stake in Sotera Health by 716.9% in the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock valued at $334,167,000 after acquiring an additional 17,560,636 shares during the period. Sessa Capital IM L.P. grew its position in shares of Sotera Health by 46.5% in the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock valued at $105,220,000 after purchasing an additional 2,000,000 shares during the period. State Street Corp grew its position in shares of Sotera Health by 18.5% in the third quarter. State Street Corp now owns 4,126,806 shares of the company’s stock valued at $68,918,000 after purchasing an additional 644,236 shares during the period. Maverick Capital Ltd. increased its stake in shares of Sotera Health by 3.5% during the third quarter. Maverick Capital Ltd. now owns 3,497,367 shares of the company’s stock worth $58,406,000 after purchasing an additional 118,353 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Sotera Health by 19.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after purchasing an additional 447,186 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.